Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Amryt Pharma plc AMYT.L
$143.00
На 18:02, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
0.00000000
-
week52high
230.00
-
week52low
89.90
-
Revenue
182607000
-
P/E TTM
-131
-
Beta
0.19762800
-
EPS
-33.00000000
-
Last Dividend
0.00000000
-
Next Earnings Date
05 ноя 2020 г. в 05:00
Описание компании
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy; oral octreotide, a long-term maintenance therapy in acromegaly patients; and lomitapide, an adjunct to a low-fat diet and other lipid-lowering medicinal products for adults with the rare cholesterol disorder. Its development candidates include Oleogel-S10 for the cutaneous manifestations of Junctional and Dystrophic Epidermolysis Bullosa (EB), a rare and distressing genetic skin disorder affecting young children and adults; and AP103, a pre-clinical gene therapy for patients with dystrophic EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | 27 июл 2021 г. | |
| Maxim Group | Buy | 31 мар 2021 г. | |
| SVB Leerink | Outperform | 16 февр 2021 г. |
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии